Malignant neoplasm of pylorus
ICD-10 C16.4 is a billable code used to indicate a diagnosis of malignant neoplasm of pylorus.
C16.4 refers to a malignant neoplasm located at the pylorus, which is the opening from the stomach into the duodenum. Gastric cancer, particularly at the pyloric region, is often associated with chronic infection by Helicobacter pylori (H. pylori), a bacterium that can lead to gastric inflammation and is a known risk factor for gastric adenocarcinoma. The clinical presentation may include symptoms such as abdominal pain, weight loss, nausea, and vomiting. Diagnosis typically involves endoscopy with biopsy, imaging studies, and staging to determine the extent of the disease. Staging is crucial as it influences treatment options, which may include surgical resection (gastrectomy), chemotherapy, and radiation therapy. Gastrectomy, particularly partial or total gastrectomy, is a common surgical intervention for pyloric malignancies, and careful coding is required to reflect the complexity of the procedure and any complications that may arise. Accurate coding for C16.4 is essential for appropriate treatment planning and reimbursement.
Detailed pathology reports, staging information, and treatment plans.
Patients presenting with gastric symptoms, diagnosed with pyloric cancer, undergoing chemotherapy or surgery.
Ensure all treatment modalities are documented, including any clinical trials or experimental therapies.
Endoscopy reports, biopsy results, and H. pylori testing documentation.
Patients with dyspepsia or gastric ulcers being evaluated for malignancy.
Document the rationale for endoscopic procedures and any findings that may indicate malignancy.
Used for patients undergoing surgical resection of pyloric malignancy.
Operative report detailing the procedure, findings, and any complications.
Ensure the surgical approach is clearly documented.
Used for diagnosis and staging of pyloric cancer.
Endoscopy report with biopsy results and any findings.
Document the indication for the procedure and any abnormalities found.
Common symptoms include abdominal pain, nausea, vomiting, weight loss, and changes in appetite. Patients may also experience gastric obstruction symptoms.
Diagnosis typically involves endoscopy with biopsy, imaging studies such as CT scans, and staging to determine the extent of the disease.
H. pylori infection is a significant risk factor for gastric cancer, including pyloric malignancies, as it can lead to chronic inflammation and dysplasia.
